According to a new study from researchers at Wake Forest University School of Medicine and The Hospital for Sick Children (SickKids) in Toronto, being born preterm is associated with an increased risk of death from birth until the third and fourth decades of life.
Atrium Health Carolinas Rehabilitation, which is a part of Advocate Health, announced the signing of a memorandum of agreement with National Rehabilitation Center UNBROKEN, a rehabilitation organization in Ukraine. This partnership aims to provide specialized education and training to enhance Ukraine's rehabilitation workforce, addressing the urgent need for rehabilitation services in a region affected by war.
A team from Wake Forest University School of Medicine and Atrium Health has been approved for a $2.5 million funding award by the Patient-Centered Outcomes Research Institute (PCORI) to help improve antibiotic prescribing for children with acute respiratory tract infections in outpatient settings.
Setting out to prove that movement indeed is medicine for older adults with chronic knee and hip pain, Wake Forest University researchers have received a $5.7 grant from the National Institutes of Health (NIH) to conduct a five-year study.
Researchers at Wake Forest University School of Medicine have received a three-year, $4.5 million grant from the Department of Defense to study cervical spine injuries in military personnel.
A new study from researchers at Wake Forest University School of Medicine shows that inpatient food insecurity, experienced by caregivers during their child’s hospitalization, is associated with not only longer hospital admissions but also significantly increased odds of readmission.
The Advisory Committee on Immunization Practices (ACIP) plays a crucial role in how the Centers for Disease Control and Prevention (CDC) sets vaccination schedules for children and adults. This work was particularly critical during the COVID-19 pandemic with the remarkable advancement of vaccines amid growing public distrust of those vaccine recommendations. To highlight the ACIP’s work during this challenging time, committee members are sharing their insights and experiences with a focus on pediatrics.
The Wake Forest Institute for Regenerative Medicine (WFIRM) is honored to announce its selection for a pioneering cancer research project that will take place aboard the International Space Station (ISS).
A new study from researchers at Wake Forest University School of Medicine is shedding light on how scientific evidence and the uncertainty surrounding three unproven therapeutics were portrayed by the U.S. news media during the early days of the COVID-19 pandemic.
The Wake Forest Institute for Regenerative Medicine (WFIRM) proudly announces the appointment of Tim Bertram, PhD, as its new Chief Ecosystem Officer. He will serve as the Chief Executive Officer (CEO) of the U.S. National Science Foundation (NSF) multi-million-dollar long-term investment in commercializing advanced regenerative medical technologies from leading North Carolina academic institutions. With an illustrious career marked by innovation and leadership, Bertram brings decades of transformative experience from his tenure at ProKidney, a leading chronic kidney disease therapy company he founded focused on preserving kidney function and controlling kidney failure.
The Wake Forest Institute for Regenerative Medicine (WFIRM) is proud to be part of a new initiative, supported by an $18 million grant from the U.S. National Science Foundation (NSF), aimed at enhancing global pandemic prediction and prevention capabilities.
Atrium Health Wake Forest Baptist’s Comprehensive Cancer Center is marking 50 years of National Cancer Institute (NCI) designation.
Researchers at Wake Forest University School of Medicine have been awarded a five-year, $3.2 million grant from the National Cancer Institute (NCI), part of the National Institutes of Health, to test a multilevel intervention in community-based oncology practices in the NCI’s Community Oncology Research Program (NCORP).
Researchers at Wake Forest University School of Medicine have received a five-year, $3.2 million grant from the National Center for Complementary and Integrative Health, part of the National Institutes of Health (NIH), to study the effectiveness of non-pharmacological treatments for migraine.
Wake Forest University School of Medicine’s Clinical and Translational Science Institute (CTSI) has been awarded $28.2 million from the National Institutes of Health. The seven-year award is the medical school’s third Clinical and Translational Science Award (CTSA), which is designed to accelerate the translation of research discoveries to improve patient care.
3DBioFibR Inc., a leader in the development of nature-inspired biomaterials, has announced its partnership with the RegeneratOR Test Bed to further its mission of revolutionizing tissue engineering.
The RegeneratOR Test Bed, located in Innovation Quarter, announces the inclusion of Cytoink into its pioneering ecosystem dedicated to advancing biomedical research and development. Cytoink brings cutting-edge biomaterials manufacturing, with over 100 custom formulations, and bioprinting expertise that merges biofunctionality with high-throughput production.
The RegenMed Development Organization (ReMDO) invites researchers, industry and academia to the inaugural Piedmont Triad Regenerative Medicine Engine Ecosystem Summit (The Summit) on Monday, August 12th in Winston-Salem, North Carolina. Registration is open to new and current partners, with required onboarding for prospective organizations to be completed by August 12. The summit will consist of speaker sessions, discussion panels, breakouts, and networking events with complete details available at http://remdo.org/2024-ecosystem-summit.
Advocate Health has been selected by the Centers for Medicare and Medicaid Services (CMS) to participate in the Guiding an Improved Dementia Experience (GUIDE) Model. Following years of neurocognitive disorders research pioneered by Advocate Health's academic core, Wake Forest University School of Medicine, patients across the health system’s footprint will now benefit from the GUIDE Model’s new standardized approach to care for patients with dementia and their caregivers.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right